Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 2 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Portable electronic device holder and tether
Storage basket with lid
Bitter taste receptors
Disk array apparatus and firmware update method therefor
Controller interface providing improved data reliability
Granulated sweetening composition
Concentration measuring apparatus for hydrogen sulfide in gas flow, and method for determining sulfide ion
  Randomly Featured Patents
Plug-in connector
Touch panel and method of manufacturing the same
Three-dimensional complex coil
Transmitting diversity communications apparatus
Method of suspending an ESP within a wellbore
Process for increasing the flavonoid content of a plant and plants obtainable thereby
Circuit board
Device for lifting, gripping and transporting printing plates
High-speed polarization-insensitive electro-optic modulator
Bronchial flow control devices and methods of use